NPI registry status
Active
2026 NPPES data Ambulatory Care Pharmacist NPI 1366178899 PHARMD, BCACP
Verify on CMS → Anna Mortali, PHARMD, BCACP
Ambulatory Care Pharmacist in Greenfield, Massachusetts.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,709 in Ambulatory Care Pharmacist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 196 beneficiaries · Ambulatory Care Pharmacist avg: 526
Generic prescribing
46%
generic claims · 51% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Anna Mortali, PHARMD, BCACP filed 2,386 Medicare Part D claims in 2024 as an Ambulatory Care Pharmacist in Greenfield, Massachusetts, prescribing 46% generic.
- 2K
- Part D claims, 2024
- 46%
- generic prescribing
- ≥86th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Anna Mortali, PHARMD, BCACP
Bare NPI registry listing — limited federal enrichment beyond basic enumeration. Verify all credentials with official sources.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1366178899), first enumerated 07/27/2022.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 2,386 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- State context
State board disciplinary context
Massachusetts statewide board action statistics are published annually — these figures describe aggregate state activity, not Anna Mortali, PHARMD, BCACP's individual license status. Verify directly with the state medical board.
Source: BORIM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
Compare Mortali with other Ambulatory Care Pharmacist providers
Same primary specialty, same federal CMS NPPES roster.
Also enrolled in Massachusetts
- Dr. Lara Abousamra, PHARMD Boston, MA
- Dr. Ikechukwu Achonye, PHARMD Boston, MA
- Dr. Uswa Ahmad, PHARMD Cambridge, MA
- Dr. Jennifer Allen, PHARMD, CDCES, BCACP Watertown, MA
- Marwah Alnewais Boston, MA
- Dr. Lily Anokhin, PHARMD Boston, MA
Other specialties in Greenfield: Mental Health Counselor (237) · Clinical Social Worker (153) · Counselor (108) · Social Worker (48)
CMS NPPES provider registry desk
NPI 1366178899 · Ambulatory Care Pharmacist
NPI-10 · ENUM-RECENT · TAX-NARROW · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1366178899
- ENUM-RECENT 2022
- TAX-NARROW 3,709
- RX-MID 2,386
- BOOK-THIN 140 in Massachusetts
- PHOTO-ENUM Anita Cheruvillil · 2022
Anna Mortali, PHARMD, BCACP's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
2,386 ≥ 86th percentile 86% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
What does the federal data show about Anna Mortali, PHARMD, BCACP?
Quality data not reportedPrimary specialty
Ambulatory Care Pharmacist
Medicare Part D claims
2,386 354% vs specialty avg
Specialty distribution in Massachusetts
How Ambulatory Care Pharmacist compares to other specialties among Massachusetts providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Ambulatory Care Pharmacist. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1366178899 |
|---|---|
| Specialty | Ambulatory Care Pharmacist |
| Credentials | PHARMD, BCACP |
| Gender | Female |
| NPI Issued | 07/27/2022 |
License & disciplinary context - Massachusetts BORIM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 - they are NOT specific to Anna Mortali, PHARMD, BCACP. To verify Anna Mortali, PHARMD, BCACP's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Anna Mortali, PHARMD, BCACP - brand share 51.0%
Ambulatory Care Pharmacist average
51% brand-name claims vs 46% generic, on 2,386 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
2,386
Total Claims
$1.0M
Total Drug Cost
196
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 4,724.933
- Total Day Supply
- 139,390
- Brand vs Generic
- 51% brand / 46% generic
- Brand Drug Cost
- $977K
- Generic Drug Cost
- $20K
Patient Demographics
- Average Patient Age
- 70.5 years
- Avg HCC Risk Score
- 1.47
- Gender Split
- 55% female / 45% male
- Age Distribution
- <65: 34, 65-74: 98, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Anna Mortali, PHARMD, BCACP prescribes most
Top Medicare Part D drugs by claim count, 2024
- Atorvastatin Calcium
Atorvastatin Calcium
185 claims
- Mounjaro
Mounjaro
175 claims
- Glipizide Er
Glipizide Er
168 claims
- Farxiga
Farxiga
167 claims
- Tradjenta
Tradjenta
140 claims
- Metformin Hcl Er
Metformin Hcl Er
120 claims
- Ozempic
Ozempic
97 claims
- Tresiba Flextouch …
Tresiba Flextouch U-200
90 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 185 |
| Mounjaro Tirzepatide | 175 |
| Glipizide Er Glipizide | 168 |
| Farxiga Dapagliflozin Propanediol | 167 |
| Tradjenta Linagliptin | 140 |
| Metformin Hcl Er Metformin Hcl | 120 |
| Ozempic Semaglutide | 97 |
| Tresiba Flextouch U-200 Insulin Degludec | 90 |
| Amlodipine Besylate | 77 |
| Lisinopril | 73 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ambulatory Care Pharmacist Overview
How Anna Mortali, PHARMD, BCACP fits within the Ambulatory Care Pharmacist landscape nationally.
3,709
Ambulatory Care Pharmacist Providers in US
52
States with Ambulatory Care Pharmacist
526
Avg Claims per Provider
Anna Mortali, PHARMD, BCACP's 2,386 claims are above the specialty average of 526.
Nationwide Ambulatory Care Pharmacist peers with similar MIPS or enrollment year
Two federal-record peer sets for Mortali, both outside Massachusetts so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2022)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Ambulatory Care Pharmacist Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as Mortali.
One of 140 Ambulatory Care Pharmacist providers enrolled in Massachusetts, 11 are shown on this page.
Dr. Leandra Battisti
PHARMD
Boston, MA
Brian Belden
Falmouth, MA
Dr. Mansi Bhatt
PHARM D
Boston, MA
Mary Bissell
Cambridge, MA
Sheri Boroda
RPH
Newton, MA
Compare Ambulatory Care Pharmacist nationally: see state-by-state distribution →
Frequently Asked Questions
What is Anna Mortali, PHARMD, BCACP's specialty? ▼
Anna Mortali, PHARMD, BCACP specializes in Ambulatory Care Pharmacist and practices in Greenfield, Massachusetts. Credentials: PHARMD, BCACP.
How much does Anna Mortali, PHARMD, BCACP prescribe under Medicare Part D? ▼
In 2024, Anna Mortali, PHARMD, BCACP wrote 2,386 Medicare Part D claims totaling $1.0M in drug costs for 196 beneficiaries.
Where is Anna Mortali, PHARMD, BCACP located? ▼
Anna Mortali, PHARMD, BCACP is located at 48 SANDERSON ST STE 201, Greenfield, MA, 01301. Phone: (413) 773-2130.
What is Anna Mortali, PHARMD, BCACP's NPI number? ▼
Anna Mortali, PHARMD, BCACP's National Provider Identifier (NPI) is 1366178899, issued on 07/27/2022.
Does Anna Mortali, PHARMD, BCACP prescribe more brand-name or generic drugs? ▼
Anna Mortali, PHARMD, BCACP's prescribing is 51% brand-name and 46% generic drugs by claim count, with $977K in brand drug costs.
How many Ambulatory Care Pharmacist providers are there in the US? ▼
There are 3,709 Ambulatory Care Pharmacist providers across 52 states in the US. The average Ambulatory Care Pharmacist provider writes 526 Medicare Part D claims per year.
What drugs does Anna Mortali, PHARMD, BCACP prescribe most often? ▼
Based on 2024 Medicare Part D data, Anna Mortali, PHARMD, BCACP's most frequently prescribed drugs include Atorvastatin Calcium, Mounjaro, Glipizide Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Anna Mortali, PHARMD, BCACP accept Medicare? ▼
Anna Mortali, PHARMD, BCACP appears in CMS Medicare data with 2,386 Part D claims and 196 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Anna Mortali, PHARMD, BCACP's credentials? ▼
Anna Mortali, PHARMD, BCACP's NPI is 1366178899 with credentials PHARMD, BCACP. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.